Health and Fitness Health and Fitness
Mon, November 12, 2012
[ Mon, Nov 12th 2012 ] - Market Wire
Biotech Industry Skyrockets in 2012 as FDA Approval Rate Increases
[ Mon, Nov 12th 2012 ] - Market Wire
350+ USANA-Sponsored Athletes Prep For Winter Sport Season
[ Mon, Nov 12th 2012 ] - Market Wire
MethylGene Announces Cdn.$26.1 Million Private Placement
[ Mon, Nov 12th 2012 ] - Market Wire
Insmed To Present At Two Upcoming Investor Conferences
[ Mon, Nov 12th 2012 ] - Market Wire
Trinity Medical Center Adds Masimo Patient Safety .. gh Vigilance Safeguard for Post-Surgical Patients
[ Mon, Nov 12th 2012 ] - Market Wire
Milestone Scientific Reports Third Quarter Financial Results and Provides Business Update
[ Mon, Nov 12th 2012 ] - Market Wire
Aeterna Zentaris Announces Initiation of Phase 2 .. Phase 1/2 Trial with AEZS-108 in Prostate Cancer
[ Mon, Nov 12th 2012 ] - Market Wire
Implant Sciences Wins Defense Contract in Middle East
[ Mon, Nov 12th 2012 ] - Market Wire
VentriPoint Expands European Network of Expert Us .. rdiac Centres in Austria, Netherlands and Germany
[ Mon, Nov 12th 2012 ] - Market Wire
Oncolytics Biotech Inc. Announces Addition to Senior Management Team
[ Mon, Nov 12th 2012 ] - Market Wire
AstraZeneca Announces Top-line Phase III Results .. ials In Patients With Opioid-Induced Constipation
[ Mon, Nov 12th 2012 ] - Market Wire
SciClone to Present at Lazard Capital Markets 9th Annual Healthcare Conference on November 14th
[ Mon, Nov 12th 2012 ] - Market Wire
Cynosure, Inc. Announces Proposed Public Offering of Class A Common Stock
[ Mon, Nov 12th 2012 ] - Market Wire
China Cord Blood Corporation Announces Completion .. Strategic Partnership with Cordlife Group Limited
Sun, November 11, 2012
[ Sun, Nov 11th 2012 ] - Market Wire
Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
[ Sun, Nov 11th 2012 ] - Market Wire
Galapagos receives positive ruling on Patent Income Deduction
[ Sun, Nov 11th 2012 ] - Market Wire
Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group
[ Sun, Nov 11th 2012 ] - Market Wire
NuVasive Announces Change of Venue for Investor Event -- Now at the W Hotel at Union Square Park
[ Sun, Nov 11th 2012 ] - Market Wire
Horizon Pharma Presents Clinical Data Demonstrati .. yed-Release Tablets Reduce Fatigue in Patients Wi
[ Sun, Nov 11th 2012 ] - Market Wire
GLPG0634 single center Proof of Concept results t .. t American College of Rheumatology Annual meeting
Sat, November 10, 2012
[ Sat, Nov 10th 2012 ] - Market Wire
Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7
[ Sat, Nov 10th 2012 ] - Market Wire
Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7
[ Sat, Nov 10th 2012 ] - Market Wire
Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7
[ Sat, Nov 10th 2012 ] - Market Wire
Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7
[ Sat, Nov 10th 2012 ] - Market Wire
Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7
[ Sat, Nov 10th 2012 ] - Market Wire
Vertex prsente de nouveaux rsultats de phase 3 qu .. atteints dahpatite C ayant reu un traitement de 2
[ Sat, Nov 10th 2012 ] - Market Wire
Gilead annuncia un tasso di risposta virologica s .. VR4) per un regime senza interferone a base di so
[ Sat, Nov 10th 2012 ] - Market Wire
Gilead annuncia un tasso di risposta virologica s .. VR4) per un regime senza interferone a base di so
Fri, November 9, 2012
[ Fri, Nov 09th 2012 ] - Market Wire
Les donnes issues d';;;;;& .. de cintique virale ont dmontr la rduction rapide
[ Fri, Nov 09th 2012 ] - Market Wire
Data from Viral Kinetic Study Showed Rapid Reduct .. (VX-135),;;;;;;;;;&
[ Fri, Nov 09th 2012 ] - Market Wire
Hansen Medical's Magellan(TM) Robotic System to B .. ITHsymposium(TM) of Vascular Surgeons and Interve
[ Fri, Nov 09th 2012 ] - Market Wire
Abbott Announces Early Tender Results for Partial .. Offers and Extends Any and All Debt Tender Offers
[ Fri, Nov 09th 2012 ] - Market Wire
Health Care Executive, Scholar and Vice Chancello .. shington, Appointed to Johnson amp;; Johns
[ Fri, Nov 09th 2012 ] - Market Wire
Jean Mixer Joins NxStage Board of Directors
[ Fri, Nov 09th 2012 ] - Market Wire
Celsion Announces Phase III HEAT Study of ThermoD .. er Reaches Target Number of Events for Unblinding
[ Fri, Nov 09th 2012 ] - Market Wire
Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting
[ Fri, Nov 09th 2012 ] - Market Wire
Omeros Responds to Misleading Announcement by Dav .. ng Settlement with Former Chief Financial Officer
[ Fri, Nov 09th 2012 ] - Market Wire
HeartWare Reports Third Quarter 2012 Results
[ Fri, Nov 09th 2012 ] - Market Wire
Novel Cancer Immune Therapy Developer Oncos Thera .. Industry Leader Frans Wuite as President and CEO
[ Fri, Nov 09th 2012 ] - Market Wire
Oncolytics Biotech Inc. Collaborators Present Pos .. Results and Research at EORTC-NCI-AACR Symposium
[ Fri, Nov 09th 2012 ] - Market Wire
IRIDEX Signs Global Licensing Agreement with QUANTEL Medical
[ Fri, Nov 09th 2012 ] - Market Wire
OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference
Thu, November 8, 2012
[ Thu, Nov 08th 2012 ] - Market Wire
Unilife's Bolus Injector Platform Targeted by Glo .. rmaceutical Company for Use in Multi-Drug Program
[ Thu, Nov 08th 2012 ] - Market Wire
Verisante Technology, Inc. Issues Operational Upd .. inics Across Canada, Distribution Sales Force Bei
[ Thu, Nov 08th 2012 ] - Market Wire
Northstar announces breakthrough new product line .. o target the $2.7 billion sports nutrition market
[ Thu, Nov 08th 2012 ] - Market Wire
Sunrise Senior Living Announces Executive Transitions
[ Thu, Nov 08th 2012 ] - Market Wire
Stem Cell Stocks Gaining Popularity in 2012 as a Result of Breakthroughs in Research
[ Thu, Nov 08th 2012 ] - Market Wire
Enzon Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China
[ Thu, Nov 08th 2012 ] - Market Wire
Cardica To Present At Lazard Capital Markets 9th Annual Healthcare Conference
[ Thu, Nov 08th 2012 ] - Market Wire
Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
[ Thu, Nov 08th 2012 ] - Market Wire
Aeterna Zentaris Presents Proof-of-Concept for Di .. s, such as AEZS-125, in Ovarian Cancer Mouse Mode
[ Thu, Nov 08th 2012 ] - Market Wire
JAMA Study Demonstrates Efficacy of Life Technolo .. ecting Early Metastases, Supports Screening for L
[ Thu, Nov 08th 2012 ] - Market Wire
Milestone Scientific and Aseptico Form Strategic Alliance
[ Thu, Nov 08th 2012 ] - Market Wire
Cornerstone Therapeutics Acquires Exclusive U.S. .. S.p.A.'s BETHKIS(R) (Tobramycin Inhalation Solut
[ Thu, Nov 08th 2012 ] - Market Wire
Omeros to Present Data from Successful OMS302 Pha .. American Academy of Ophthalmology Annual Meeting
[ Thu, Nov 08th 2012 ] - Market Wire
MethylGene Presents MGCD265 Data at the 24th EORT .. sium on Molecular Targets and Cancer Therapeutics
Wed, November 7, 2012
[ Wed, Nov 07th 2012 ] - Market Wire
Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer
[ Wed, Nov 07th 2012 ] - Market Wire
BIOLASE to Present at Lazard Capital Markets 9th Annual Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
Johnson amp;; Johnson to Participate in Credit Suisse 2012 Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
VIVUS, Micron, Oracle, Hewlett-Packard, AOL, and MIPS Technologies
[ Wed, Nov 07th 2012 ] - Market Wire
VistaGen Therapeutics and Duke University Announc .. ogress at American Heart Association 2012 Scienti
[ Wed, Nov 07th 2012 ] - Market Wire
Graphite Corp. Increases Land Position to 1700 Acres in Montana
[ Wed, Nov 07th 2012 ] - Market Wire
ImmuCell Announces Product Sales Increases and Other Financial Results
[ Wed, Nov 07th 2012 ] - Market Wire
Zynex Schedules Third Quarter 2012 Earnings Release and Webcast
[ Wed, Nov 07th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Presentation .. Capital Markets 9th Annual Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
Aeterna Zentaris to Announce Third Quarter 2012 F .. ancial and Operating Results on November 13, 2012
[ Wed, Nov 07th 2012 ] - Market Wire
Syneron Medical Appoints Jonathan Pearson as Exec .. esident of Business Development, Topical Products
[ Wed, Nov 07th 2012 ] - Market Wire
IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
[ Wed, Nov 07th 2012 ] - Market Wire
Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
Misonix Reports Strong Revenue Increases for the First Quarter of Fiscal 2013
Tue, November 6, 2012
[ Tue, Nov 06th 2012 ] - Market Wire
Uroplasty To Participate In Two Upcoming Investor Conferences
[ Tue, Nov 06th 2012 ] - Market Wire
Sunrise Senior Living Applauds Utility Companies Following Hurricane Sandy
[ Tue, Nov 06th 2012 ] - Market Wire
CooperSurgical Launches The Reengineered Carter-Thomason II Port Closure System
[ Tue, Nov 06th 2012 ] - Market Wire
LX4211 Phase 2b Results Presented At American Heart Association Annual Conference
[ Tue, Nov 06th 2012 ] - Market Wire
Syneron presenta i suoi innovativi prodotti per l .. ollaborazione con la BODY Conference and Exhibiti
[ Tue, Nov 06th 2012 ] - Market Wire
Vista Partners Updates Coverage on ADVENTRX Pharm .. icals, Inc.;; Raises Target Price to $4.50
[ Tue, Nov 06th 2012 ] - Market Wire
00 a.m. ET on Friday, November 9, 2012
[ Tue, Nov 06th 2012 ] - Market Wire
Sarepta Therapeutics to Present Company Overview .. Capital Markets 9th Annual Healthcare Conference
[ Tue, Nov 06th 2012 ] - Market Wire
Rigel Announces Third Quarter 2012 Financial Results
[ Tue, Nov 06th 2012 ] - Market Wire
Implant Sciences QS-B220 Explosives and Drugs Tra .. in Government Security News Homeland Security Aw
[ Tue, Nov 06th 2012 ] - Market Wire
Response Genetics, Inc. to Release Third Quarter .. lts and Host Conference Call on November 13, 2012
[ Tue, Nov 06th 2012 ] - Market Wire
ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012
[ Tue, Nov 06th 2012 ] - Market Wire
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
[ Tue, Nov 06th 2012 ] - Market Wire
Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
Mon, November 5, 2012
[ Mon, Nov 05th 2012 ] - Market Wire
Cardica Announces Fiscal 2013 First Quarter Financial Results
[ Mon, Nov 05th 2012 ] - Market Wire
Six New Plaintiffs Join Sanford Heisler's $100m G .. tion Against Forest Laboratories & Forest Pharmac
[ Mon, Nov 05th 2012 ] - Market Wire
Results from the Largest Known Cholesterol Survey .. ced at the American Heart Association's Annual Sc
[ Mon, Nov 05th 2012 ] - Market Wire
PharmAthene To Host Third Quarter 2012 Conference Call And Webcast On Tuesday, November 6, 2012
[ Mon, Nov 05th 2012 ] - Market Wire
Medisafe 1 Technologies Announces Delay in Closin .. 7MM Perpetual License Sale Due to Hurricane Sandy
[ Mon, Nov 05th 2012 ] - Market Wire
CTLM(R) 3D Laser Breast Imaging System Sold and Shipped to Romania
[ Mon, Nov 05th 2012 ] - Market Wire
Array BioPharma To Present Clinical Data At The 2 .. A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 In
[ Mon, Nov 05th 2012 ] - Market Wire
Medicure Announces Agreement to Promote Aggrastat(R) in the Commonwealth of Puerto Rico
[ Mon, Nov 05th 2012 ] - Market Wire
NuVasive Announces Change of Date for Investor Event -- Now to Be Held on November 14, 2012
[ Mon, Nov 05th 2012 ] - Market Wire
Syneron Destaca sus Productos innovadores en lipo .. in con la Conferencia y Exposicin BODY en Londres
[ Mon, Nov 05th 2012 ] - Market Wire
Life Technologies Acquires Advanced Microscopy Group
[ Mon, Nov 05th 2012 ] - Market Wire
AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
[ Mon, Nov 05th 2012 ] - Market Wire
Record First Quarter for Greystone Logistics
[ Mon, Nov 05th 2012 ] - Market Wire
VolitionRx's Preliminary Diagnostic Clinical Tria .. ty and Specificity for Colon, Breast and Lung Can
Sat, November 3, 2012
[ Sat, Nov 03rd 2012 ] - Market Wire
Phase 3 Sensipar/Mimpara EVOLVEa" Trial Published In The New England Journal Of Medicine
Fri, November 2, 2012
[ Fri, Nov 02nd 2012 ] - Market Wire
Lpath Announces Filing of Shelf Registration Statement
[ Fri, Nov 02nd 2012 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation Into Abiomed, Inc.
[ Fri, Nov 02nd 2012 ] - Market Wire
Medivation Announces Third Quarter 2012 Financial Results Teleconference on November 9, 2012
[ Fri, Nov 02nd 2012 ] - Market Wire
Centene Corporation Announces Pricing Of Notes
[ Fri, Nov 02nd 2012 ] - Market Wire
Block amp;; Leviton LLP Investigates Abiom .. ficers and Directors for Possible Violations of t
[ Fri, Nov 02nd 2012 ] - Market Wire
Hill-Rom to Participate in the Credit Suisse 2012 Healthcare Conference
[ Fri, Nov 02nd 2012 ] - Market Wire
Amgen To Present Data From Four Phase 2 Studies A .. erican Heart Association Scientific Sessions 2012
[ Fri, Nov 02nd 2012 ] - Market Wire
Abbott and the Abbott Fund Donate $1 Million in F .. roducts to Support Hurricane Sandy Relief Efforts
[ Fri, Nov 02nd 2012 ] - Market Wire
HealthTronics Launches New Line Of Slimline Cryoprobes For Use With Its Endocare Cryocare Systems
[ Fri, Nov 02nd 2012 ] - Market Wire
Analyst Opinion on Health Management Associates I .. . -- Hospitals Post Mixed Quarterly Results, Lowe
[ Fri, Nov 02nd 2012 ] - Market Wire
Analyst Opinion on Universal Health Services Inc. .. s Inc. -- Hospitals Post Mixed Quarterly Results,
[ Fri, Nov 02nd 2012 ] - Market Wire
Celsion Corporation to Hold Third Quarter 2012 Fi .. ults Conference Call on Monday, November 12, 2012
[ Fri, Nov 02nd 2012 ] - Market Wire
Implant Sciences Awarded Contract to Deploy Explo .. t Nigerian Corporation to Protect Against Terrori
[ Fri, Nov 02nd 2012 ] - Market Wire
Titan Medical Inc. Announces Memorandum of Understanding With The University of Florida
Thu, November 1, 2012
[ Thu, Nov 01st 2012 ] - Market Wire
Cornerstone Therapeutics to Host Third Quarter 2012 Conference Call
[ Thu, Nov 01st 2012 ] - Market Wire
HealthSouth to Present at Investor Conferences in November
[ Thu, Nov 01st 2012 ] - Market Wire
Halozyme to Host Third Quarter Financial Results Conference Call
[ Thu, Nov 01st 2012 ] - Market Wire
CombiMatrix Corporation Selects Cartagenia BENCHl .. b CNV Platform to Bolster Expanded Lab Operations
[ Thu, Nov 01st 2012 ] - Market Wire
Financial Review on Healthcare Stocks Teva Pharma .. Allergan Inc. -- Drug Manufacturers Focusing on E
[ Thu, Nov 01st 2012 ] - Market Wire
BioTech Medics, Inc. Signs Letter of Interest Wit .. or $5 Million Cross-Marketing Licensing Agreement
[ Thu, Nov 01st 2012 ] - Market Wire
Hansen Medical Announces Third Quarter 2012 Results Conference Call
[ Thu, Nov 01st 2012 ] - Market Wire
Cornerstone Therapeutics Receives Complete Response Letter From the FDA for Lixivaptan
[ Thu, Nov 01st 2012 ] - Market Wire
Life Technologies Collaborates with USDA to Devel .. p Same-Day, Multi-Strain E. coli Detection System
[ Thu, Nov 01st 2012 ] - Market Wire
Accuray Receives FDA 510(k) Clearance for New Cyb .. Multileaf Collimation with Non-Isocentric Robotic
[ Thu, Nov 01st 2012 ] - Market Wire
30 a.m. ET November 8, 2012 to Discuss Third Quarter 2012 Results
[ Thu, Nov 01st 2012 ] - Market Wire
AcelRx Pharmaceuticals to Hold Third Quarter 2012 .. s Conference Call and Webcast on November 6, 2012
[ Thu, Nov 01st 2012 ] - Market Wire
Neovasc Inc. Finalizes US $4.6 Million Agreement .. ts to In-House Manufacture of Xenosure Surgical P
[ Thu, Nov 01st 2012 ] - Market Wire
Digirad Corporation Reports 2012 Third Quarter and Nine-Month Financial Results
Wed, October 31, 2012
[ Wed, Oct 31st 2012 ] - Market Wire
Watson Announces New Name -- Actavis -- for Global Operations
[ Wed, Oct 31st 2012 ] - Market Wire
Watson Completes Actavis Acquisition
[ Wed, Oct 31st 2012 ] - Market Wire
Arena Pharmaceuticals to Host Corporate Update an .. onference Call and Webcast on Tuesday, November 6
[ Wed, Oct 31st 2012 ] - Market Wire
Varian Medical Systems Highlights a Comprehensive .. lio for the Non-Invasive Treatment of Lung Cancer
[ Wed, Oct 31st 2012 ] - Market Wire
Dynavax to Initiate Phase 1 Studies for TLR-9 Agonist for Asthma
[ Wed, Oct 31st 2012 ] - Market Wire
MethylGene to Present MGCD265 Data at the 24th EO .. sium on Molecular Targets and Cancer Therapeutics
[ Wed, Oct 31st 2012 ] - Market Wire
Kennedy Health System Renews System-Wide Pulse Oximetry Contract with Masimo
[ Wed, Oct 31st 2012 ] - Market Wire
Genomic Health to Announce Third Quarter 2012 Fin .. st Conference Call on Wednesday, November 7, 2012
[ Wed, Oct 31st 2012 ] - Market Wire
American Board of Radiology Foundation receives g .. dical Systems for national brachytherapy registry
[ Wed, Oct 31st 2012 ] - Market Wire
Isis Pharmaceuticals Reports Encouraging Interim .. se 1 Data On ISIS-STAT3Rx In Patients With Cancer
[ Wed, Oct 31st 2012 ] - Market Wire
Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call
[ Wed, Oct 31st 2012 ] - Market Wire
NewLink Genetics Corporation Reports Third Quarter 2012 Financial Results
[ Wed, Oct 31st 2012 ] - Market Wire
Hansen Medical Announces Expanded Agreement With Intuitive Surgical
[ Wed, Oct 31st 2012 ] - Market Wire
Lexicon to Provide Third Quarter 2012 Financial Results
Tue, October 30, 2012
[ Tue, Oct 30th 2012 ] - Market Wire
OncoGenex to Webcast Discussion of Third Quarter .. 2 Financial Results on Thursday, November 8, 2012
[ Tue, Oct 30th 2012 ] - Market Wire
Sarepta Therapeutics Announces Third Quarter 2012 .. cial Results and Corporate Update Conference Call
[ Tue, Oct 30th 2012 ] - Market Wire
Arrhythmia Research Technologies, Inc. Appoints Michael Gunter as Interim CEO
[ Tue, Oct 30th 2012 ] - Market Wire
Johnson amp;; Johnson Postpones Medical Devices amp;; Diagnostics Review
[ Tue, Oct 30th 2012 ] - Market Wire
Medicure Reports First Quarter Financial Results for Fiscal 2013
[ Tue, Oct 30th 2012 ] - Market Wire
Lilly Names Melissa Barnes Chief Ethics and Compl .. e President;; Announces Retirement of Anne
[ Tue, Oct 30th 2012 ] - Market Wire
Calyx's Operating Subsidiary Makes Aviation History, Powers the World's First 100% Biofuel Flight
[ Tue, Oct 30th 2012 ] - Market Wire
Revenue Growth and Expenditure Control at the Core of Revised Business Plan
[ Tue, Oct 30th 2012 ] - Market Wire
European Commission approves Cialis (tadalafil) t .. he signs and symptoms of benign prostatic hyperpl
[ Tue, Oct 30th 2012 ] - Market Wire
Horizon Pharma to Host Conference Call and Webcas .. arter 2012 Financial Results on November 13, 2012
Mon, October 29, 2012
[ Mon, Oct 29th 2012 ] - Market Wire
Masimo Reschedules Release of Third Quarter 2012 .. ted Conference Call to Thursday, November 1st Due
[ Mon, Oct 29th 2012 ] - Market Wire
MSA Engineer Named Rising Star of Safety by the National Safety Council
[ Mon, Oct 29th 2012 ] - Market Wire
BIOLASE to Discuss Third Quarter 2012 Financial Results on November 5, 2012 Conference Call
[ Mon, Oct 29th 2012 ] - Market Wire
Analyst Opinion on Eli Lilly &;; Co. an .. turers Countering Patent Expirations with New Pro
[ Mon, Oct 29th 2012 ] - Market Wire
Watson Announces Sale of Rugby OTC Product Tradem .. aceuticals, a division of The Harvard Drug Group,
[ Mon, Oct 29th 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Thir .. ts and Host a Conference Call to Update Investors
[ Mon, Oct 29th 2012 ] - Market Wire
IsoRay's Brain and Lung Cancer Products Showcased .. Society for Radiation Oncology (ASTRO) Convention
[ Mon, Oct 29th 2012 ] - Market Wire
ProPhase Labs Rejects Non-Binding Revised Proposa .. xx Initiatives to Be Acquired for $1.60 per Share
[ Mon, Oct 29th 2012 ] - Market Wire
Theratechnologies to Host Conference Call
[ Mon, Oct 29th 2012 ] - Market Wire
Bioheart to Initiate ANGEL Trial in Mexico
[ Mon, Oct 29th 2012 ] - Market Wire
Former Under Secretary of Homeland Security Asa H .. Having a Personal Health Record for Emergency Pre
[ Mon, Oct 29th 2012 ] - Market Wire
Stem Cell Therapeutics Announces Admission to Cen .. zation of Regenerative Medicine (CCRM) Consortium
[ Mon, Oct 29th 2012 ] - Market Wire
BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
Sun, October 28, 2012
[ Sun, Oct 28th 2012 ] - Market Wire
Varian Medical Systems Unveils EDGEa" Radiosurger .. ive Solution for Non-Invasive Surgical Procedures
[ Sun, Oct 28th 2012 ] - Market Wire
Accuray Launches New TomoTherapy Ha" Series Featuring TomoEDGEa"
Fri, October 26, 2012
[ Fri, Oct 26th 2012 ] - Market Wire
Watson Receives FDA Approval for Generic Actos
[ Fri, Oct 26th 2012 ] - Market Wire
NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System
[ Fri, Oct 26th 2012 ] - Market Wire
Abbott Announces Cash Tender Offers for Notes
[ Fri, Oct 26th 2012 ] - Market Wire
Accelerated Growth in Terms of Sales and Profitability at Ergoresearch Ltd
[ Fri, Oct 26th 2012 ] - Market Wire
Factors of Influence, Economy and Policy -- Resea .. Celgene Corporation and Teva Pharmaceutical Indu
[ Fri, Oct 26th 2012 ] - Market Wire
Timing Is Crucial, Upside Analysis - New Outlook on Aetna Inc. and Cigna Corporation
[ Fri, Oct 26th 2012 ] - Market Wire
Identifying Opportunity, Placing Risk - Consensus .. gen Idec Inc. and Regeneron Pharmaceuticals, Inc.
[ Fri, Oct 26th 2012 ] - Market Wire
CareFusion To Report Preliminary Fiscal 2013 First Quarter Results On Nov. 8
[ Fri, Oct 26th 2012 ] - Market Wire
Watson Confirms FDA Denies Appeal Related to Prochieve NDA for the Prevention of Preterm Birth
[ Fri, Oct 26th 2012 ] - Market Wire
Substantial Clinical Evidence and Adoption Presen .. ay's TomoTherapy Asia Pacific Users' Meeting 2012
[ Fri, Oct 26th 2012 ] - Market Wire
Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
[ Fri, Oct 26th 2012 ] - Market Wire
Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
[ Fri, Oct 26th 2012 ] - Market Wire
Implant Sciences Provides QS-B220 Qualification Testing Update
Thu, October 25, 2012
[ Thu, Oct 25th 2012 ] - Market Wire
Volcano Corporation Schedules Third Quarter Conference Call, Webcast
[ Thu, Oct 25th 2012 ] - Market Wire
Unilife Corporation To Announce Financial Results .. l 2013 First Quarter On Tuesday, October 30, 2012
[ Thu, Oct 25th 2012 ] - Market Wire
Insulet Appoints John A. Fallon to Board of Directors
[ Thu, Oct 25th 2012 ] - Market Wire
IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
[ Thu, Oct 25th 2012 ] - Market Wire
Brookdale Announces Third Quarter 2012 Release and Earnings Call
[ Thu, Oct 25th 2012 ] - Market Wire
Critical Alerts For Gilead, United Technologies, .. gs, CIT, and ResMed Released By InvestorsObserver
[ Thu, Oct 25th 2012 ] - Market Wire
Critical Alerts For Pfizer, LinkedIn, SAP, Fortun .. curity, and Toll Brothers Released By InvestorsOb
[ Thu, Oct 25th 2012 ] - Market Wire
Orexigen Therapeutics Prices Public Offering of Common Stock
[ Thu, Oct 25th 2012 ] - Market Wire
International Stem Cell Corp's Lifeline Cell Tech .. ducts to Be Added to Fisher Scientific's Catalogs
[ Thu, Oct 25th 2012 ] - Market Wire
Dynamic Energy Alliance Initiates Prototype Phase of Organic Compound Fractionator
[ Thu, Oct 25th 2012 ] - Market Wire
Access Pharmaceuticals Announces Private Placement Financing
[ Thu, Oct 25th 2012 ] - Market Wire
Warnex to Sell its Bioanalytical Services Division
[ Thu, Oct 25th 2012 ] - Market Wire
Given Imaging to Host Third Quarter 2012 Financial Results Conference Call on November 7, 2012
Wed, October 24, 2012
[ Wed, Oct 24th 2012 ] - Market Wire
Neurocrine Biosciences Announces Conference Call .. t to Present Third Quarter 2012 Financial Results
[ Wed, Oct 24th 2012 ] - Market Wire
Anthera Pharmaceuticals Reports 2012 Third Quarte .. ial Results And Provides Clinical Progress Update
[ Wed, Oct 24th 2012 ] - Market Wire
HealthSouth Executes Letter of Intent To Purchase .. alton Rehabilitation Hospital in Augusta, Georgia
[ Wed, Oct 24th 2012 ] - Market Wire
PTS, Inc. (PTSH) Management's Address To The Market
[ Wed, Oct 24th 2012 ] - Market Wire
Sangamo BioSciences Reports Third Quarter 2012 Financial Results
[ Wed, Oct 24th 2012 ] - Market Wire
Orexigen Therapeutics Announces Proposed Public Offering of Common Stock
[ Wed, Oct 24th 2012 ] - Market Wire
Given Imaging Reports Data Showing Greater Role f .. scopy in Detecting and Monitoring Crohn's Disease
[ Wed, Oct 24th 2012 ] - Market Wire
Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

Transcept Pharmaceuticals to Report Third Quarter 2012 Financial Results and Host Conference Call on November 12, 2012


//health-fitness.news-articles.net/content/2012/ .. nd-host-conference-call-on-november-12-2012.html
Published in Health and Fitness on Tuesday, November 6th 2012 at 14:01 GMT by Market Wire   Print publication without navigation


Transcept Pharmaceuticals to Report Third Quarter 2012 Financial Results and Host... -- POINT RICHMOND, Calif., Nov. 6, 2012 /PRNewswire/ --

[ ]

[ Download image ]

POINT RICHMOND, Calif., Nov. 6, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: [ TSPT ]), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Monday, November 12, 2012, at 4:30 p.m. Eastern Time to discuss its third quarter 2012 financial results. The conference call will follow the release of the Transcept third quarter 2012 financial results after the close of market that day.

Conference Call Information





Date: Monday, November 12, 2012


Time: 4:30 p.m. ET


Dial-in (U.S.): 877-638-4558


Dial-in (International): 914-495-8537

A simultaneous webcast of the conference call will be available on the Investors section of the Transcept website at [ www.transcept.com ]. A replay of this webcast will be available on the website shortly after the conclusion of the call through January 30, 2013.

About Transcept

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Intermezzo® (zolpidem tartrate) sublingual tablet C-IV is the first FDA approved Transcept product. Purdue Pharma holds commercialization and development rights for Intermezzo in the United States. Transcept is currently conducting a Phase 2 study of an investigational product, TO-2061, in patients with obsessive-compulsive disorder. For further information about Transcept, please visit [ www.transcept.com ]. For information about Intermezzo, please visit [ www.IntermezzoRx.com ].

Contact:
Transcept Pharmaceuticals, Inc.
Greg Mann
Sr. Director, Corporate Communications
(510) 215-3567
[ gmann@transcept.com ]

SOURCE Transcept Pharmaceuticals, Inc.



RELATED LINKS
[ http://www.transcept.com ]

Publication Contributing Sources